{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:12:43Z","timestamp":1791886363904,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/B\/ST4\/00485"],"award-info":[{"award-number":["2017\/27\/B\/ST4\/00485"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurodegenerative diseases, such as Alzheimer\u2019s disease (AD) and various types of amyloidosis, are incurable; therefore, understanding the mechanisms of amyloid decomposition is crucial to develop an effective drug against them for future therapies. It has been reported that one out of three people over the age of 85 are suffering from dementia as a comorbidity to AD. Amyloid beta (A\u03b2), the hallmark of AD, transforms structurally from monomers into \u03b2-stranded aggregates (fibrils) via multiple oligomeric states. Astrocytes in the central nervous system secrete the human cystatin C protein (HCC) in response to various proteases and cytokines. The codeposition of A\u03b2 and HCC in the brains of patients with AD led to the hypothesis that cystatin C is implicated in the disease process. In this study, we investigate the intermolecular interactions between different atomic structures of fibrils formed by A\u03b2 peptides and HCC to understand the pathological aggregation of these polypeptides into neurotoxic oligomers and then amyloid plaques. To characterize the interactions between A\u03b2 and HCC, we used a complementary approach based on the combination of small-angle neutron scattering analysis, atomic force microscopy and computational modelling, allowing the exploration of the structures of multicomponent protein complexes. We report here an optimized protocol to study that interaction. The results show a dependency of the sequence length of the A\u03b2 peptide on the ability of the associated HCC to disaggregate it.<\/jats:p>","DOI":"10.1038\/s41598-023-47514-w","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T15:17:26Z","timestamp":1701098246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view"],"prefix":"10.1038","volume":"13","author":[{"given":"Adriana","family":"\u017by\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Jurczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustyn","family":"Moli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"47514_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbd.2014.07.011","volume":"71","author":"A Pensalfini","year":"2014","unstructured":"Pensalfini, A. et al. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol. Dis. 71, 53\u201361 (2014).","journal-title":"Neurobiol. Dis."},{"key":"47514_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2990.1986.tb00053.x","volume":"12","author":"DMA Mann","year":"1986","unstructured":"Mann, D. M. A., Yates, P. O., Marcyniuk, B. & Ravindra, C. R. The topography of plaques and tangles in Down\u2019s syndrome patients of different ages. Neuropathol. Appl. Neurobiol. 12, 447\u2013457 (1986).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"47514_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"W-Q Zhao","year":"2009","unstructured":"Zhao, W.-Q. & Townsend, M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochim. Biophys. Acta BBA Mol. Basis Dis. 1792, 482\u2013496 (2009).","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"47514_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner, G. G. & Wong, C. W. Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885\u2013890 (1984).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47514_CR5","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris, G. P., Clark, I. A. & Vissel, B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 2, 135 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"47514_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor, P. N. et al. A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J. Neurosci. 27, 796\u2013807 (2007).","journal-title":"J. Neurosci."},{"key":"47514_CR7","first-page":"597","volume":"3","author":"NA Shirwany","year":"2007","unstructured":"Shirwany, N. A., Payette, D., Xie, J. & Guo, Q. The amyloid beta ion channel hypothesis of Alzheimer\u2019s disease. Neuropsychiatr. Dis. Treat. 3, 597\u2013612 (2007).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"47514_CR8","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1016\/j.bpj.2008.11.056","volume":"96","author":"P Picone","year":"2009","unstructured":"Picone, P. et al. A\u03b2 oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Biophys. J. 96, 4200\u20134211 (2009).","journal-title":"Biophys. J."},{"key":"47514_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","volume":"12","author":"VW Chow","year":"2010","unstructured":"Chow, V. W., Mattson, M. P., Wong, P. C. & Gleichmann, M. An overview of APP processing enzymes and products. NeuroMol. Med. 12, 1\u201312 (2010).","journal-title":"NeuroMol. Med."},{"key":"47514_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40478-016-0294-7","volume":"4","author":"J Reinert","year":"2016","unstructured":"Reinert, J. et al. Deposition of C-terminally truncated A\u03b2 species A\u03b237 and A\u03b239 in Alzheimer\u2019s disease and transgenic mouse models. Acta Neuropathol. Commun. 4, 24 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"47514_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran, E. & De Strooper, B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat. Rev. Drug Discov. 21, 306\u2013318 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"47514_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/pri.3.2.8859","volume":"3","author":"M F\u00e4ndrich","year":"2009","unstructured":"F\u00e4ndrich, M., Meinhardt, J. & Grigorieff, N. Structural polymorphism of Alzheimer A\u03b2 and other amyloid fibrils. Prion 3, 89\u201393 (2009).","journal-title":"Prion"},{"key":"47514_CR13","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1016\/j.febslet.2009.07.003","volume":"583","author":"SK Maji","year":"2009","unstructured":"Maji, S. K., Wang, L., Greenwald, J. & Riek, R. Structure-activity relationship of amyloid fibrils. FEBS Lett. 583, 2610\u20132617 (2009).","journal-title":"FEBS Lett."},{"key":"47514_CR14","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1039\/C7CS00372B","volume":"46","author":"PC Ke","year":"2017","unstructured":"Ke, P. C. et al. Implications of peptide assemblies in amyloid diseases. Chem. Soc. Rev. 46, 6492\u20136531 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"47514_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan, R. & Reddy, P. H. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J. Alzheimers Dis. 57, 975\u2013999 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"47514_CR16","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms20194661","volume":"20","author":"B Mroczko","year":"2019","unstructured":"Mroczko, B., Groblewska, M. & Litman-Zawadzka, A. The role of protein misfolding and tau oligomers (TauOs) in Alzheimer\u2032s disease (AD). Int. J. Mol. Sci. 20, 4661 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"47514_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2045-8118-10-15","volume":"10","author":"ME Wilson","year":"2013","unstructured":"Wilson, M. E., Boumaza, I. & Bowser, R. Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects. Fluids Barriers CNS 10, 15 (2013).","journal-title":"Fluids Barriers CNS"},{"key":"47514_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0002-9440(10)61781-6","volume":"159","author":"A Deng","year":"2001","unstructured":"Deng, A., Irizarry, M. C., Nitsch, R. M., Growdon, J. H. & Rebeck, G. W. Elevation of cystatin C in susceptible neurons in Alzheimer\u2019s disease. Am. J. Pathol. 159, 1061\u20131068 (2001).","journal-title":"Am. J. Pathol."},{"key":"47514_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jnen\/60.1.94","volume":"60","author":"E Levy","year":"2001","unstructured":"Levy, E. et al. Codeposition of cystatin C with amyloid-\u03b2 protein in the brain of Alzheimer disease patients. J. Neuropathol. Exp. Neurol. 60, 11 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"47514_CR20","doi-asserted-by":"publisher","first-page":"e2854","DOI":"10.1038\/cddis.2017.240","volume":"8","author":"J Zou","year":"2017","unstructured":"Zou, J. et al. Cystatin C as a potential therapeutic mediator against Parkinson\u2019s disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units. Cell Death Dis. 8, e2854\u2013e2854 (2017).","journal-title":"Cell Death Dis."},{"key":"47514_CR21","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1038\/s41598-020-61383-7","volume":"10","author":"K Maniwa","year":"2020","unstructured":"Maniwa, K. et al. Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects. Sci. Rep. 10, 4688 (2020).","journal-title":"Sci. Rep."},{"key":"47514_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0065-2423(01)35015-1","volume":"35","author":"AO Grubb","year":"2001","unstructured":"Grubb, A. O. Cystatin C-Properties and use as diagnostic marker. Adv. Clin. Chem. 35, 63\u201399 (2001).","journal-title":"Adv. Clin. Chem."},{"key":"47514_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5507\/bp.2003.025","volume":"147","author":"J Mare\u0161","year":"2003","unstructured":"Mare\u0161, J. et al. Use of cystatin C determination in clinical diagnostics. Biomed. Pap. 147, 177\u2013180 (2003).","journal-title":"Biomed. Pap."},{"key":"47514_CR24","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1073\/pnas.91.4.1416","volume":"91","author":"M Abrahamson","year":"1994","unstructured":"Abrahamson, M. & Grubb, A. Increased body temperature accelerates aggregation of the Leu-68 \u2192 Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc. Natl. Acad. Sci. U. S. A. 91, 1416\u20131420 (1994).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"47514_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/86188","volume":"8","author":"R Janowski","year":"2001","unstructured":"Janowski, R. et al. Human cystatin C, an amyloidogenic protein, dimerizes through three- dimensional domain swapping. Nat. Struct. Biol. 8, 5 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"47514_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/icb.2014.121","volume":"93","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Ding, Y., Li, X. & Wu, X. Cystatin C is a disease-associated protein subject to multiple regulation. Immunol. Cell Biol. 93, 442\u2013451 (2015).","journal-title":"Immunol. Cell Biol."},{"key":"47514_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/febs.15010","volume":"287","author":"M Maszota-Zieleniak","year":"2020","unstructured":"Maszota-Zieleniak, M. et al. NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution. FEBS J. 287, 361\u2013376 (2020).","journal-title":"FEBS J."},{"key":"47514_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/prot.20633","volume":"61","author":"R Janowski","year":"2005","unstructured":"Janowski, R., Kozak, M., Abrahamson, M., Grubb, A. & Jaskolski, M. 3D domain-swapped human cystatin C with amyloidlike intermolecular \u03b2-sheets. Proteins Struct. Funct. Bioinform. 61, 570\u2013578 (2005).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"47514_CR29","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1107\/S090744499901121X","volume":"55","author":"M Kozak","year":"1999","unstructured":"Kozak, M. et al. Expression of a selenomethionyl derivative and preliminary crystallographic studies of human cystatin C. Acta Crystallogr. D Biol. Crystallogr. 55, 1939\u20131942 (1999).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"47514_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1107\/S0907444912051657","volume":"69","author":"M Orlikowska","year":"2013","unstructured":"Orlikowska, M. et al. Structural characterization of V57D and V57P mutants of human cystatin C, an amyloidogenic protein. Acta Crystallogr. D Biol. Crystallogr. 69, 577\u2013586 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"47514_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jmb.2004.06.013","volume":"341","author":"R Janowski","year":"2004","unstructured":"Janowski, R., Abrahamson, M., Grubb, A. & Jaskolski, M. Domain swapping in N-truncated human cystatin C. J. Mol. Biol. 341, 151\u2013160 (2004).","journal-title":"J. Mol. Biol."},{"key":"47514_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jsb.2010.11.009","volume":"173","author":"M Orlikowska","year":"2011","unstructured":"Orlikowska, M., Jankowska, E., Ko\u0142odziejczyk, R., Jask\u00f3lski, M. & Szyma\u0144ska, A. Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C. J. Struct. Biol. 173, 406\u2013413 (2011).","journal-title":"J. Struct. Biol."},{"key":"47514_CR33","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1742-4658.2010.07596.x","volume":"277","author":"R Kolodziejczyk","year":"2010","unstructured":"Kolodziejczyk, R. et al. Crystal structure of human cystatin C stabilized against amyloid formation: Structure of monomeric cystatin C. FEBS J. 277, 1726\u20131737 (2010).","journal-title":"FEBS J."},{"key":"47514_CR34","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1074\/jbc.M117.786558","volume":"292","author":"TJ Perlenfein","year":"2017","unstructured":"Perlenfein, T. J., Mehlhoff, J. D. & Murphy, R. M. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with \u03b2-amyloid. J. Biol. Chem. 292, 11485\u201311498 (2017).","journal-title":"J. Biol. Chem."},{"key":"47514_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/13506120009146827","volume":"7","author":"\u00cd \u00d3lafsson","year":"2000","unstructured":"\u00d3lafsson, \u00cd. & Grubb, A. Hereditary cystatin C amyloid angiopathy. Amyloid 7, 70\u201379 (2000).","journal-title":"Amyloid"},{"key":"47514_CR36","doi-asserted-by":"publisher","first-page":"8548","DOI":"10.1038\/s41598-019-44811-1","volume":"9","author":"M Taube","year":"2019","unstructured":"Taube, M. et al. The domain swapping of human cystatin C induced by synchrotron radiation. Sci. Rep. 9, 8548 (2019).","journal-title":"Sci. Rep."},{"key":"47514_CR37","doi-asserted-by":"publisher","first-page":"16438","DOI":"10.1074\/jbc.M113.469593","volume":"288","author":"G \u00d6stner","year":"2013","unstructured":"\u00d6stner, G. et al. Stabilization, characterization, and selective removal of cystatin C amyloid oligomers. J. Biol. Chem. 288, 16438\u201316450 (2013).","journal-title":"J. Biol. Chem."},{"key":"47514_CR38","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.3390\/ijms21165860","volume":"21","author":"M Chrab\u0105szczewska","year":"2020","unstructured":"Chrab\u0105szczewska, M. et al. Structural characterization of covalently stabilized human cystatin C oligomers. Int. J. Mol. Sci. 21, 5860 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"47514_CR39","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1111\/j.1742-4658.2010.07721.x","volume":"277","author":"VN Uversky","year":"2010","unstructured":"Uversky, V. N. Mysterious oligomerization of the amyloidogenic proteins: Oligomerization of amyloidogenic proteins. FEBS J. 277, 2940\u20132953 (2010).","journal-title":"FEBS J."},{"key":"47514_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/febs.15010","volume":"287","author":"M Maszota-Zieleniak","year":"2020","unstructured":"Maszota-Zieleniak, M. et al. NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution. FEBS J. 287, 361\u2013376 (2020).","journal-title":"FEBS J."},{"key":"47514_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/00365510601009738","volume":"67","author":"ML Selenica","year":"2007","unstructured":"Selenica, M. L., Wang, X., Ostergaard-Pedersen, L., Westlind-Danielsson, A. & Grubb, A. Cystatin C reduces the in vitro formation of soluble A\u03b21-42 oligomers and protofibrils. Scand. J. Clin. Lab. Invest. 67, 179\u2013190 (2007).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"47514_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ng.2007.23","volume":"39","author":"SA Kaeser","year":"2007","unstructured":"Kaeser, S. A. et al. Cystatin C modulates cerebral \u03b2-amyloidosis. Nat. Genet. 39, 1437\u20131439 (2007).","journal-title":"Nat. Genet."},{"key":"47514_CR43","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/ng.2007.29","volume":"39","author":"W Mi","year":"2007","unstructured":"Mi, W. et al. Cystatin C inhibits amyloid-\u03b2 deposition in Alzheimer\u2019s disease mouse models. Nat. Genet. 39, 1440\u20131442 (2007).","journal-title":"Nat. Genet."},{"key":"47514_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JAD-2010-1291","volume":"19","author":"B Tizon","year":"2010","unstructured":"Tizon, B., Ribe, E. M., Mi, W., Troy, C. M. & Levy, E. Cystatin c protects neuronal cells from amyloid-\u03b2-induced toxicity. J. Alzheimers Dis. 19, 885\u2013894 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"47514_CR45","doi-asserted-by":"publisher","first-page":"e0161093","DOI":"10.1371\/journal.pone.0161093","volume":"11","author":"X-F Wang","year":"2016","unstructured":"Wang, X.-F. et al. Cystatin C shifts APP processing from amyloid-\u03b2 production towards non-amyloidgenic pathway in brain endothelial cells. PLoS One 11, e0161093 (2016).","journal-title":"PLoS One"},{"key":"47514_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jmb.2008.04.014","volume":"379","author":"A Per\u00e1lvarez-Mar\u00edn","year":"2008","unstructured":"Per\u00e1lvarez-Mar\u00edn, A., Barth, A. & Gr\u00e4slund, A. Time-resolved infrared spectroscopy of pH-induced aggregation of the Alzheimer A\u03b21\u201328 peptide. J. Mol. Biol. 379, 589\u2013596 (2008).","journal-title":"J. Mol. Biol."},{"key":"47514_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/cn3000247","volume":"3","author":"S Sinha","year":"2012","unstructured":"Sinha, S., Lopes, D. H. J. & Bitan, G. A key role for lysine residues in amyloid \u03b2-protein folding, assembly, and toxicity. ACS Chem. Neurosci. 3, 473\u2013481 (2012).","journal-title":"ACS Chem. Neurosci."},{"key":"47514_CR48","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.7717\/peerj.73","volume":"1","author":"TM Ryan","year":"2013","unstructured":"Ryan, T. M. et al. Ammonium hydroxide treatment of A\u03b2 produces an aggregate free solution suitable for biophysical and cell culture characterization. PeerJ 1, e73 (2013).","journal-title":"PeerJ"},{"key":"47514_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-60761-744-0_2","volume-title":"Alzheimer\u2019s disease and frontotemporal dementia","author":"WB Stine","year":"2010","unstructured":"Stine, W. B., Jungbauer, L., Yu, C. & Ladu, M. J. preparing synthetic a\u03b2 in different aggregation states. In Alzheimer\u2019s disease and frontotemporal dementia Vol. 670 (ed. Roberson, E. D.) 13\u201332 (Humana Press, 2010)."},{"key":"47514_CR50","doi-asserted-by":"publisher","first-page":"13441","DOI":"10.3390\/ijms232113441","volume":"23","author":"D Wojciechowska","year":"2022","unstructured":"Wojciechowska, D., Taube, M., Ruci\u0144ska, K., Maksim, J. & Kozak, M. Oligomerization of human cystatin C\u2014An amyloidogenic protein: An analysis of small oligomeric subspecies. Int. J. Mol. Sci. 23, 13441 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"47514_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1011254402785","volume":"20","author":"J Marley","year":"2001","unstructured":"Marley, J., Lu, M. & Bracken, C. A method for efficient isotopic labeling of recombinant proteins. J. Biomol. NMR 20, 71\u201375 (2001).","journal-title":"J. Biomol. NMR"},{"key":"47514_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10858-018-00222-4","volume":"73","author":"SB Azatian","year":"2019","unstructured":"Azatian, S. B., Kaur, N. & Latham, M. P. Increasing the buffering capacity of minimal media leads to higher protein yield. J. Biomol. NMR 73, 11\u201317 (2019).","journal-title":"J. Biomol. NMR"},{"key":"47514_CR53","first-page":"166","volume":"20","author":"J Pollak","year":"2010","unstructured":"Pollak, J., Szymanska, A., Lindstrom, V. & Grubb, A. Production of cystatin C wild type and stabilized mutants. EJIFCC 20, 166\u2013170 (2010).","journal-title":"EJIFCC"},{"key":"47514_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1140\/epje\/i2013-13071-6","volume":"36","author":"C Breyton","year":"2013","unstructured":"Breyton, C. et al. Small angle neutron scattering for the study of solubilised membrane proteins. Eur. Phys. J. E 36, 71 (2013).","journal-title":"Eur. Phys. J. E"},{"key":"47514_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10858-016-0052-y","volume":"66","author":"M Cai","year":"2016","unstructured":"Cai, M., Huang, Y., Yang, R., Craigie, R. & Clore, G. M. A simple and robust protocol for high-yield expression of perdeuterated proteins in Escherichia coli grown in shaker flasks. J. Biomol. NMR 66, 85\u201391 (2016).","journal-title":"J. Biomol. NMR"},{"key":"47514_CR56","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1107\/S1600576723007379","volume":"56","author":"CD Dewhurst","year":"2023","unstructured":"Dewhurst, C. D. Graphical reduction and analysis small-angle neutron scattering program: GRASP. J. Appl. Cryst. 56, 1595\u22121609 (2023).","journal-title":"J. Appl. Cryst."},{"key":"47514_CR57","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1107\/S0021889806035059","volume":"39","author":"SR Kline","year":"2006","unstructured":"Kline, S. R. Reduction and analysis of SANS and USANS data using IGOR Pro. J. Appl. Crystallogr. 39, 895\u2013900 (2006).","journal-title":"J. Appl. Crystallogr."},{"key":"47514_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1107\/S1600576720013412","volume":"54","author":"K Manalastas-Cantos","year":"2021","unstructured":"Manalastas-Cantos, K. et al. ATSAS 3.0: Expanded functionality and new tools for small-angle scattering data analysis. J. Appl. Crystallogr. 54, 343\u2013355 (2021).","journal-title":"J. Appl. Crystallogr."},{"key":"47514_CR59","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1107\/S1600576721010293","volume":"54","author":"CJ Gommes","year":"2021","unstructured":"Gommes, C. J., Jaksch, S. & Frielinghaus, H. Small-angle scattering for beginners. J. Appl. Crystallogr. 54, 1832\u20131843 (2021).","journal-title":"J. Appl. Crystallogr."},{"key":"47514_CR60","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1107\/S1600576719002012","volume":"52","author":"PA Penttil\u00e4","year":"2019","unstructured":"Penttil\u00e4, P. A., Rautkari, L., \u00d6sterberg, M. & Schweins, R. Small-angle scattering model for efficient characterization of wood nanostructure and moisture behaviour. J. Appl. Crystallogr. 52, 369\u2013377 (2019).","journal-title":"J. Appl. Crystallogr."},{"key":"47514_CR61","doi-asserted-by":"publisher","first-page":"012030","DOI":"10.1088\/1742-6596\/247\/1\/012030","volume":"247","author":"K Lepp\u00e4nen","year":"2010","unstructured":"Lepp\u00e4nen, K. et al. Small-angle x-ray scattering study on the structure of microcrystalline and nanofibrillated cellulose. J. Phys. Conf. Ser. 247, 012030 (2010).","journal-title":"J. Phys. Conf. Ser."},{"key":"47514_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1039\/D1SM01707A","volume":"18","author":"D McDowall","year":"2022","unstructured":"McDowall, D., Adams, D. J. & Seddon, A. M. Using small angle scattering to understand low molecular weight gels. Soft Matter 18, 1577\u20131590 (2022).","journal-title":"Soft Matter"},{"key":"47514_CR63","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer, M. et al. Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat. Commun. 10, 4760 (2019).","journal-title":"Nat. Commun."},{"key":"47514_CR64","doi-asserted-by":"publisher","first-page":"W304","DOI":"10.1093\/nar\/gky328","volume":"46","author":"C Czaplewski","year":"2018","unstructured":"Czaplewski, C., Karczy\u0144ska, A., Sieradzan, A. K. & Liwo, A. UNRES server for physics-based coarse-grained simulations and prediction of protein structure, dynamics and thermodynamics. Nucleic Acids Res. 46, W304\u2013W309 (2018).","journal-title":"Nucleic Acids Res."},{"key":"47514_CR65","doi-asserted-by":"publisher","first-page":"W419","DOI":"10.1093\/nar\/gkv456","volume":"43","author":"M Kurcinski","year":"2015","unstructured":"Kurcinski, M., Jamroz, M., Blaszczyk, M., Kolinski, A. & Kmiecik, S. CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res. 43, W419\u2013W424 (2015).","journal-title":"Nucleic Acids Res."},{"key":"47514_CR66","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1021\/jm801115e","volume":"52","author":"P Juszczyk","year":"2009","unstructured":"Juszczyk, P. et al. Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with \u03b2-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation. J. Med. Chem. 52, 2420\u20132428 (2009).","journal-title":"J. Med. Chem."},{"key":"47514_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2478\/s11534-011-0096-2","volume":"10","author":"D Ne\u010das","year":"2012","unstructured":"Ne\u010das, D. & Klapetek, P. Gwyddion: An open-source software for SPM data analysis. Open Phys. 10, 181\u2013188 (2012).","journal-title":"Open Phys."},{"key":"47514_CR68","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/ph14080732","volume":"14","author":"A Santoro","year":"2021","unstructured":"Santoro, A., Grimaldi, M., Buonocore, M., Stillitano, I. & D\u2019Ursi, A. M. Exploring the early stages of the amyloid A\u03b2(1\u201342) peptide aggregation process: An NMR study. Pharmaceuticals 14, 732 (2021).","journal-title":"Pharmaceuticals"},{"key":"47514_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nsmb.2991","volume":"22","author":"Y Xiao","year":"2015","unstructured":"Xiao, Y. et al. A\u03b2(1\u201342) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease. Nat. Struct. Mol. Biol. 22, 499\u2013505 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"47514_CR70","doi-asserted-by":"publisher","first-page":"E4976","DOI":"10.1073\/pnas.1600749113","volume":"113","author":"MA W\u00e4lti","year":"2016","unstructured":"W\u00e4lti, M. A. et al. Atomic-resolution structure of a disease-relevant A\u03b2(1\u201342) amyloid fibril. Proc. Natl. Acad. Sci. 113, E4976\u2013E4984 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"47514_CR71","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","volume":"27","author":"C R\u00f6der","year":"2020","unstructured":"R\u00f6der, C. et al. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-\u03b2 fibrils. Nat. Struct. Mol. Biol. 27, 660\u2013667 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"47514_CR72","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0196-9781(02)00061-X","volume":"23","author":"A Parbhu","year":"2002","unstructured":"Parbhu, A., Lin, H., Thimm, J. & Lal, R. Imaging real-time aggregation of amyloid beta protein (1\u201342) by atomic force microscopy. Peptides 23, 1265\u20131270 (2002).","journal-title":"Peptides"},{"key":"47514_CR73","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/nprot.2016.113","volume":"11","author":"CM Jeffries","year":"2016","unstructured":"Jeffries, C. M. et al. Preparing monodisperse macromolecular samples for successful biological small-angle X-ray and neutron-scattering experiments. Nat. Protoc. 11, 2122\u20132153 (2016).","journal-title":"Nat. Protoc."},{"key":"47514_CR74","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.3390\/molecules25235624","volume":"25","author":"D Lombardo","year":"2020","unstructured":"Lombardo, D., Calandra, P. & Kiselev, M. A. Structural characterization of biomaterials by means of small angle X-rays and neutron scattering (SAXS and SANS), and light scattering experiments. Molecules 25, 5624 (2020).","journal-title":"Molecules"},{"key":"47514_CR75","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.nano.2012.03.005","volume":"8","author":"B Klajnert","year":"2012","unstructured":"Klajnert, B. et al. Dendrimers reduce toxicity of A\u03b2 1\u201328 peptide during aggregation and accelerate fibril formation. Nanomed. Nanotechnol. Biol. Med. 8, 1372\u20131378 (2012).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"47514_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0006-3495(93)81312-2","volume":"65","author":"C-L Shen","year":"1993","unstructured":"Shen, C.-L., Scott, G. L., Merchant, F. & Murphy, R. M. Light scattering analysis of fibril growth from the amino-terminal fragment 13(1\u201328) of 13-amyloid peptide. Biophys. J. 65, 13 (1993).","journal-title":"Biophys. J."},{"key":"47514_CR77","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3233\/JAD-2010-100396","volume":"21","author":"PK Mandal","year":"2010","unstructured":"Mandal, P. K., Bhavesh, N. S., Chauhan, V. S. & Fodale, V. NMR investigations of amyloid-\u03b2 peptide interactions with propofol at clinically relevant concentrations with and without aqueous halothane solution. J. Alzheimers Dis. 21, 1303\u20131309 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"47514_CR78","doi-asserted-by":"publisher","first-page":"23818","DOI":"10.1074\/jbc.M701078200","volume":"282","author":"IH Cheng","year":"2007","unstructured":"Cheng, I. H. et al. Accelerating amyloid-\u03b2 fibrillization reduces oligomer levels and functional deficits in alzheimer disease mouse models. J. Biol. Chem. 282, 23818\u201323828 (2007).","journal-title":"J. Biol. Chem."},{"key":"47514_CR79","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","volume":"276","author":"SA Hudson","year":"2009","unstructured":"Hudson, S. A., Ecroyd, H., Kee, T. W. & Carver, J. A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds: Exogenous compounds can bias thioflavin T assays. FEBS J. 276, 5960\u20135972 (2009).","journal-title":"FEBS J."},{"key":"47514_CR80","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1107\/S0907444910017658","volume":"66","author":"WT Heller","year":"2010","unstructured":"Heller, W. T. Small-angle neutron scattering and contrast variation: A powerful combination for studying biological structures. Acta Crystallogr. D Biol. Crystallogr. 66, 1213\u20131217 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"47514_CR81","doi-asserted-by":"publisher","first-page":"29200","DOI":"10.1038\/srep29200","volume":"6","author":"P Bergstr\u00f6m","year":"2016","unstructured":"Bergstr\u00f6m, P. et al. Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation. Sci. Rep. 6, 29200 (2016).","journal-title":"Sci. Rep."},{"key":"47514_CR82","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JAD-2012-120508","volume":"31","author":"E Portelius","year":"2012","unstructured":"Portelius, E. et al. Amyloid-\u03b21-15\/16 as a marker for \u03b3-secretase inhibition in Alzheimer\u2019s disease. J. Alzheimers Dis. 31, 335\u2013341 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"47514_CR83","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/bi00191a006","volume":"33","author":"J Talafous","year":"1994","unstructured":"Talafous, J., Marcinowski, K. J., Klopman, G. & Zagorski, M. G. Solution structure of residues 1\u201328 of the amyloid, \u03b2 peptide+. Biochemistry 33, 7788\u20137796 (1994).","journal-title":"Biochemistry"},{"key":"47514_CR84","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1021\/cb5008663","volume":"10","author":"MM Rahman","year":"2015","unstructured":"Rahman, M. M., Zetterberg, H., Lendel, C. & H\u00e4rd, T. Binding of human proteins to amyloid-\u03b2 protofibrils. ACS Chem. Biol. 10, 766\u2013774 (2015).","journal-title":"ACS Chem. Biol."},{"key":"47514_CR85","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2003.11.006","volume":"25","author":"M Sastre","year":"2004","unstructured":"Sastre, M. et al. Binding of cystatin C to Alzheimer\u2019s amyloid \u03b2 inhibits in vitro amyloid fibril formation. Neurobiol. Aging 25, 1033\u20131043 (2004).","journal-title":"Neurobiol. Aging"},{"key":"47514_CR86","doi-asserted-by":"publisher","first-page":"18258","DOI":"10.1073\/pnas.0509276102","volume":"102","author":"L Cruz","year":"2005","unstructured":"Cruz, L. et al. Solvent and mutation effects on the nucleation of amyloid \u03b2-protein folding. Proc. Natl. Acad. Sci. 102, 18258\u201318263 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"47514_CR87","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.bpj.2011.10.023","volume":"101","author":"VS Mithu","year":"2011","unstructured":"Mithu, V. S. et al. Zn++ binding disrupts the Asp23-Lys28 salt bridge without altering the hairpin-shaped cross-\u03b2 structure of A\u03b242 amyloid aggregates. Biophys. J. 101, 2825\u20132832 (2011).","journal-title":"Biophys. J."},{"key":"47514_CR88","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/07391102.2012.748535","volume":"31","author":"Y Song","year":"2013","unstructured":"Song, Y., Xu, L., Shen, M. & He, J. Roles of hydrophobic and hydrophilic forces on maintaining amyloid-prone cystatin structural stability. J. Biomol. Struct. Dyn. 31, 978\u2013981 (2013).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"47514_CR89","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-2836(84)90309-7","volume":"179","author":"D Eisenberg","year":"1984","unstructured":"Eisenberg, D., Schwarz, E., Komaromy, M. & Wall, R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179, 125\u2013142 (1984).","journal-title":"J. Mol. Biol."},{"key":"47514_CR90","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.3390\/ijms22116075","volume":"22","author":"B Wiatrak","year":"2021","unstructured":"Wiatrak, B., Piasny, J., Ku\u017aniarski, A. & G\u0105siorowski, K. Interactions of amyloid-\u03b2 with membrane proteins. Int. J. Mol. Sci. 22, 6075 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"47514_CR91","doi-asserted-by":"publisher","first-page":"C890","DOI":"10.1107\/S0108767321088085","volume":"77","author":"P Kozminski","year":"2021","unstructured":"Kozminski, P. et al. Photoswitchable dismantlers of biomaterials made of amyloid fibrils. Acta Crystallogr. Sect. Found. Adv. 77, C890\u2013C890 (2021).","journal-title":"Acta Crystallogr. Sect. Found. Adv."},{"key":"47514_CR92","doi-asserted-by":"publisher","first-page":"e15709","DOI":"10.1371\/journal.pone.0015709","volume":"5","author":"J Waters","year":"2010","unstructured":"Waters, J. The concentration of soluble extracellular amyloid-\u03b2 protein in acute brain slices from CRND8 mice. PLoS One 5, e15709 (2010).","journal-title":"PLoS One"},{"key":"47514_CR93","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1021\/acschemneuro.8b00065","volume":"9","author":"N \u00d6sterlund","year":"2018","unstructured":"\u00d6sterlund, N. et al. Amyloid-\u03b2 peptide interactions with amphiphilic surfactants: Electrostatic and hydrophobic effects. ACS Chem. Neurosci. 9, 1680\u20131692 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"47514_CR94","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/aps.2011.14","volume":"32","author":"Q Nie","year":"2011","unstructured":"Nie, Q., Du, X. & Geng, M. Small molecule inhibitors of amyloid \u03b2 peptide aggregation as a potential therapeutic strategy for Alzheimer\u2019s disease. Acta Pharmacol. Sin. 32, 545\u2013551 (2011).","journal-title":"Acta Pharmacol. Sin."},{"key":"47514_CR95","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00266","author":"Y Jin","year":"2023","unstructured":"Jin, Y., Downey, M. A., Singh, A., Buratto, S. K. & Bowers, M. T. Computationally designed small molecules disassemble both soluble oligomers and protofibrils of amyloid \u03b2-protein responsible for Alzheimer\u2019s disease. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.3c00266 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"47514_CR96","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1021\/acschemneuro.1c00235","volume":"12","author":"A Pasieka","year":"2021","unstructured":"Pasieka, A. et al. Dual inhibitors of amyloid-\u03b2 and tau aggregation with amyloid-\u03b2 disaggregating properties: extended in cellulo, in silico, and kinetic studies of multifunctional anti-Alzheimer\u2019s agents. ACS Chem. Neurosci. 12, 2057\u20132068 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"47514_CR97","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","volume":"94","author":"B Solomon","year":"1997","unstructured":"Solomon, B., Koppel, R., Frankel, D. & Hanan-Aharon, E. Disaggregation of Alzheimer \u03b2-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. U. S. A. 94, 4109\u20134112 (1997).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"47514_CR98","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/ijms23042011","volume":"23","author":"S Silvestro","year":"2022","unstructured":"Silvestro, S., Valeri, A. & Mazzon, E. Aducanumab and its effects on tau pathology: Is this the turning point of amyloid hypothesis?. Int. J. Mol. Sci. 23, 2011 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"47514_CR99","doi-asserted-by":"publisher","first-page":"790939","DOI":"10.3389\/fnagi.2021.790939","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Changes in serum Cystatin C levels and the associations with cognitive function in Alzheimer\u2019s disease patients. Front. Aging Neurosci. 13, 790939 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"47514_CR100","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-2009-1147","volume":"18","author":"W Mi","year":"2009","unstructured":"Mi, W. et al. Complexes of amyloid-\u03b2 and cystatin c in the human central nervous system. J. Alzheimers Dis. 18, 273\u2013280 (2009).","journal-title":"J. Alzheimers Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47514-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47514-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47514-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T15:26:14Z","timestamp":1701098774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47514-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47514-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20833"}}